Early aldosterone up-regulated genes: new pathways for renal disease
Early aldosterone up-regulated genes: New pathways for renal disease? Background - The use of aldosterone antagonists has important beneficial effects on the progression of renal and cardiac disease reflected in a decrease of cardiovascular mortality and renal failure. Nevertheless, the incidence of...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 October 2003
|
| In: |
Kidney international
Year: 2003, Jahrgang: 64, Heft: 4, Pages: 1199-1207 |
| ISSN: | 1523-1755 |
| DOI: | 10.1046/j.1523-1755.2003.00216.x |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1046/j.1523-1755.2003.00216.x Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0085253815494554 
|
| Verfasserangaben: | Markus Kellner, Angela Peiter, Mathias Hafner, Martin Feuring, Michael Christ, Martin Wehling, Elisabeth Falkenstein, Ralf Lösel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1815191171 | ||
| 003 | DE-627 | ||
| 005 | 20230710173242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220825s2003 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1046/j.1523-1755.2003.00216.x |2 doi | |
| 035 | |a (DE-627)1815191171 | ||
| 035 | |a (DE-599)KXP1815191171 | ||
| 035 | |a (OCoLC)1389825589 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kellner, Markus |e VerfasserIn |0 (DE-588)1266341757 |0 (DE-627)1815181540 |4 aut | |
| 245 | 1 | 0 | |a Early aldosterone up-regulated genes |b new pathways for renal disease |c Markus Kellner, Angela Peiter, Mathias Hafner, Martin Feuring, Michael Christ, Martin Wehling, Elisabeth Falkenstein, Ralf Lösel |
| 264 | 1 | |c 1 October 2003 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.08.2022 | ||
| 520 | |a Early aldosterone up-regulated genes: New pathways for renal disease? Background - The use of aldosterone antagonists has important beneficial effects on the progression of renal and cardiac disease reflected in a decrease of cardiovascular mortality and renal failure. Nevertheless, the incidence of heart and end-stage renal failure continues to increase. This leads to the conclusion that mechanisms independent of the classical aldosterone/mineralocorticoid receptor system may contribute to the pathogenesis of cardiac and renal disease. - Methods - The mRNA expression profile of human renal epithelial cells in response to aldosterone was characterized using cDNA arrays covering ∼1430 genes. Differentially expressed genes were further evaluated by quantitative reverse transcription-polymerase chain reaction (RT-PCR), Northern blotting, and estimating the gene products by Western blotting. - Results - Aldosterone treatment of cells resulted in significant up-regulation of several genes within 1 hour, with sgk, p21/waf1, gadd45, and gadd153 being the most significant ones. Long-term treatment (>4 hours) with aldosterone induced the mRNA expression of pparα and purα. The mineralocorticoid receptor inhibitor spironolactone decreased the mRNA levels of sgk, p21/waf1, and gadd45, whereas the glucocorticoid receptor inhibitor RU 486 reduced the mRNA level of sgk and p21/waf1. Gadd153 was not affected by any of the inhibitors, probably indicating regulation by nonclassic mechanisms. - Conclusion - Among the early genes investigated in this study, one transcript has been identified that is not suppressed by antagonists of either glucocorticoid or mineralocorticoid receptor. Further studies should be able to identify other genes regulated in a similar manner that could explain the inefficacy of spironolactone in some cases of aldosterone-mediated kidney disease. | ||
| 650 | 4 | |a aldosterone | |
| 650 | 4 | |a gene regulation | |
| 650 | 4 | |a kidney | |
| 650 | 4 | |a nonclassic receptors | |
| 650 | 4 | |a renal disease | |
| 650 | 4 | |a spironolactone | |
| 700 | 1 | |a Peiter, Angela |d 1973- |e VerfasserIn |0 (DE-588)121936554 |0 (DE-627)705708306 |0 (DE-576)293003955 |4 aut | |
| 700 | 1 | |a Hafner, Mathias |d 1956- |e VerfasserIn |0 (DE-588)1027781187 |0 (DE-627)729718379 |0 (DE-576)375302956 |4 aut | |
| 700 | 1 | |a Feuring, Martin |d 1963-2018 |e VerfasserIn |0 (DE-588)1075744083 |0 (DE-627)833665383 |0 (DE-576)176498125 |4 aut | |
| 700 | 1 | |a Christ, Michael |e VerfasserIn |0 (DE-588)1104517590 |0 (DE-627)861919009 |0 (DE-576)471121649 |4 aut | |
| 700 | 1 | |a Wehling, Martin |d 1957- |e VerfasserIn |0 (DE-588)129939331 |0 (DE-627)484463152 |0 (DE-576)297912577 |4 aut | |
| 700 | 1 | |a Falkenstein, Elisabeth |e VerfasserIn |0 (DE-588)1079182314 |0 (DE-627)840589506 |0 (DE-576)184625319 |4 aut | |
| 700 | 1 | |a Lösel, Ralf M. |e VerfasserIn |0 (DE-588)1076384633 |0 (DE-627)834823152 |0 (DE-576)168946661 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney international |d New York, NY : Elsevier, 1972 |g 64(2003), 4, Seite 1199-1207 |h Online-Ressource |w (DE-627)32046637X |w (DE-600)2007940-0 |w (DE-576)091143004 |x 1523-1755 |7 nnas |a Early aldosterone up-regulated genes new pathways for renal disease |
| 773 | 1 | 8 | |g volume:64 |g year:2003 |g number:4 |g pages:1199-1207 |g extent:9 |a Early aldosterone up-regulated genes new pathways for renal disease |
| 856 | 4 | 0 | |u https://doi.org/10.1046/j.1523-1755.2003.00216.x |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0085253815494554 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220825 | ||
| 994 | |a 2003 | ||
| 998 | |g 1076384633 |a Lösel, Ralf M. |m 1076384633:Lösel, Ralf M. |d 60000 |d 65400 |e 60000PL1076384633 |e 65400PL1076384633 |k 0/60000/ |k 1/60000/65400/ |p 8 |y j | ||
| 998 | |g 1079182314 |a Falkenstein, Elisabeth |m 1079182314:Falkenstein, Elisabeth |d 60000 |d 65400 |e 60000PF1079182314 |e 65400PF1079182314 |k 0/60000/ |k 1/60000/65400/ |p 7 | ||
| 998 | |g 129939331 |a Wehling, Martin |m 129939331:Wehling, Martin |d 60000 |d 65400 |e 60000PW129939331 |e 65400PW129939331 |k 0/60000/ |k 1/60000/65400/ |p 6 | ||
| 998 | |g 1104517590 |a Christ, Michael |m 1104517590:Christ, Michael |p 5 | ||
| 998 | |g 1075744083 |a Feuring, Martin |m 1075744083:Feuring, Martin |d 60000 |d 65400 |e 60000PF1075744083 |e 65400PF1075744083 |k 0/60000/ |k 1/60000/65400/ |p 4 | ||
| 998 | |g 1027781187 |a Hafner, Mathias |m 1027781187:Hafner, Mathias |d 60000 |e 60000PH1027781187 |k 0/60000/ |p 3 | ||
| 998 | |g 1266341757 |a Kellner, Markus |m 1266341757:Kellner, Markus |d 60000 |d 65400 |e 60000PK1266341757 |e 65400PK1266341757 |k 0/60000/ |k 1/60000/65400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1815191171 |e 4182735382 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Markus","family":"Kellner","display":"Kellner, Markus","role":"aut"},{"display":"Peiter, Angela","family":"Peiter","given":"Angela","role":"aut"},{"given":"Mathias","family":"Hafner","display":"Hafner, Mathias","role":"aut"},{"family":"Feuring","given":"Martin","display":"Feuring, Martin","role":"aut"},{"display":"Christ, Michael","given":"Michael","family":"Christ","role":"aut"},{"role":"aut","display":"Wehling, Martin","family":"Wehling","given":"Martin"},{"role":"aut","display":"Falkenstein, Elisabeth","family":"Falkenstein","given":"Elisabeth"},{"display":"Lösel, Ralf M.","family":"Lösel","given":"Ralf M.","role":"aut"}],"title":[{"title":"Early aldosterone up-regulated genes","subtitle":"new pathways for renal disease","title_sort":"Early aldosterone up-regulated genes"}],"origin":[{"dateIssuedKey":"2003","dateIssuedDisp":"1 October 2003"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 25.08.2022"],"recId":"1815191171","id":{"doi":["10.1046/j.1523-1755.2003.00216.x"],"eki":["1815191171"]},"name":{"displayForm":["Markus Kellner, Angela Peiter, Mathias Hafner, Martin Feuring, Michael Christ, Martin Wehling, Elisabeth Falkenstein, Ralf Lösel"]},"relHost":[{"origin":[{"publisher":"Elsevier ; Blackwell ; Wiley-Blackwell ; Nature Publishing Group","dateIssuedDisp":"1972-","publisherPlace":"New York, NY ; Oxford [u.a.] ; [Erscheinungsort nicht ermittelbar] ; Basingstoke","dateIssuedKey":"1972"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"official journal of the International Society of Nephrology","title_sort":"Kidney international","title":"Kidney international"}],"pubHistory":["1.1972 -"],"note":["Gesehen am 20.08.20"],"recId":"32046637X","id":{"eki":["32046637X"],"zdb":["2007940-0"],"issn":["1523-1755"]},"language":["eng"],"disp":"Early aldosterone up-regulated genes new pathways for renal diseaseKidney international","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"64(2003), 4, Seite 1199-1207","issue":"4","year":"2003","extent":"9","pages":"1199-1207","volume":"64"},"corporate":[{"display":"International Society of Nephrology","role":"isb"}]}],"physDesc":[{"extent":"9 S."}],"language":["eng"]} | ||
| SRT | |a KELLNERMAREARLYALDOS1200 | ||